PDSB
Price
$1.32
Change
+$0.09 (+7.32%)
Updated
Apr 24 closing price
Capitalization
59.92M
19 days until earnings call
RXRX
Price
$5.76
Change
+$0.01 (+0.17%)
Updated
Apr 25, 11:45 AM (EDT)
Capitalization
2.31B
12 days until earnings call
Ad is loading...

PDSB vs RXRX

Header iconPDSB vs RXRX Comparison
Open Charts PDSB vs RXRXBanner chart's image
PDS Biotechnology
Price$1.32
Change+$0.09 (+7.32%)
Volume$264.85K
Capitalization59.92M
Recursion Pharmaceuticals
Price$5.76
Change+$0.01 (+0.17%)
Volume$9.67K
Capitalization2.31B
PDSB vs RXRX Comparison Chart
Loading...
PDSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PDSB vs. RXRX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PDSB is a Buy and RXRX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (PDSB: $1.32 vs. RXRX: $5.75)
Brand notoriety: PDSB and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PDSB: 35% vs. RXRX: 55%
Market capitalization -- PDSB: $59.92M vs. RXRX: $2.31B
PDSB [@Biotechnology] is valued at $59.92M. RXRX’s [@Biotechnology] market capitalization is $2.31B. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PDSB’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • PDSB’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, both PDSB and RXRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PDSB’s TA Score shows that 5 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • PDSB’s TA Score: 5 bullish, 4 bearish.
  • RXRX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PDSB is a better buy in the short-term than RXRX.

Price Growth

PDSB (@Biotechnology) experienced а +22.22% price change this week, while RXRX (@Biotechnology) price change was +4.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

PDSB is expected to report earnings on Aug 13, 2025.

RXRX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.31B) has a higher market cap than PDSB($59.9M). RXRX YTD gains are higher at: -14.941 vs. PDSB (-19.018). PDSB has higher annual earnings (EBITDA): -36.65M vs. RXRX (-426.72M). RXRX has more cash in the bank: 594M vs. PDSB (49.8M). PDSB has less debt than RXRX: PDSB (24.7M) vs RXRX (108M). RXRX has higher revenues than PDSB: RXRX (58.5M) vs PDSB (0).
PDSBRXRXPDSB / RXRX
Capitalization59.9M2.31B3%
EBITDA-36.65M-426.72M9%
Gain YTD-19.018-14.941127%
P/E RatioN/AN/A-
Revenue058.5M-
Total Cash49.8M594M8%
Total Debt24.7M108M23%
FUNDAMENTALS RATINGS
PDSB: Fundamental Ratings
PDSB
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
PROFIT vs RISK RATING
1..100
94
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PDSBRXRX
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 1 day ago
86%
N/A
Declines
ODDS (%)
Bearish Trend 22 days ago
88%
Bearish Trend 18 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
87%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Ad is loading...
PDSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FTAI101.375.54
+5.78%
FTAI Aviation Ltd
NHTC4.970.10
+2.13%
Natural Health Trends Corp
ANIK14.380.29
+2.06%
Anika Therapeutics
BKNG4827.9796.94
+2.05%
Booking Holdings
GSBD10.760.09
+0.84%
Goldman Sachs BDC

PDSB and

Correlation & Price change

A.I.dvisor indicates that over the last year, PDSB has been loosely correlated with RXRX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if PDSB jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDSB
1D Price
Change %
PDSB100%
+7.32%
RXRX - PDSB
46%
Loosely correlated
+3.05%
ATOS - PDSB
46%
Loosely correlated
-0.73%
KYMR - PDSB
45%
Loosely correlated
+9.32%
AXON - PDSB
43%
Loosely correlated
+2.39%
CRNX - PDSB
43%
Loosely correlated
+3.15%
More